Author:
Gorkin L.,Follick M. J.,Geltman E.,Hamm P.,Sollano J. S.,Sylvia S.,Jacobson K.,Jacobson M. J.,Cochrane B. S.,Sussex B.,Klein M.,Gaudette G.,Goldman D.,Carrol D.,Holcombe R.,Abern D. K.,
Publisher
Springer Science and Business Media LLC
Subject
Public Health, Environmental and Occupational Health
Reference30 articles.
1. Guyatt GH, Thompson PH, Berman LB, et al. How should we measure function in patients with chronic heart and lung disease? J Chronic Dis 1985; 18: 517?524.
2. Tandon PK, Stander H, Dyke SH, et al. Assessment of the quality of life of patients with heart failure: a randomized controlled drug trial. Heart Failure 1988; 4: 39?54.
3. Feinstein AR, Fischer MB, Pigeon JG. Changes in dyspnea-fatigue ratings as indicators of quality of life in the treatment of congestive heart failure. Am J Cardiol 1989; 64: 50?55.
4. Moye LA, Pfeffer MA, Braunwald E, for the SAVE Inverstigators. Design and baseline characteristics of the Survival and Ventricular Enlargement (SAVE) trial. Am J Cardiol 1991; 68: 700?707.
5. Pfeffer MA, Lamas GA, Vaughan DE, et al. Effect of captopril on progressive ventricular dilation after anterior infarction. N Engl J Med 1988; 319: 80?86.
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献